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Background: Despite progress towards End TB Strategy targets for reducing tuberculosis (TB) 
incidence and deaths by 2035, South Africa remains among the top ten high-burden 
tuberculosis countries globally. A large challenge lies in how policies to improve detection, 
diagnosis and treatment completion interact with social and structural drivers of TB. Detailed 
understanding and theoretical development of the contextual determinants of problems in 
TB care is required for developing effective interventions. This article reports findings from 
the pre-implementation phase of a study of TB care in South Africa, contributing to HeAlth 
System StrEngThening in Sub-Saharan Africa (ASSET) - a five-year research programme 
developing and evaluating health system strengthening interventions in sub-Saharan Africa. 
The study aimed to develop hypothetical propositions regarding contextual determinants of 
problems in TB care to inform intervention development to reduce TB deaths and incidence 
whilst ensuring the delivery of quality integrated, person-centred care.  
Methods: Theory-building case study design using the Context and Implementation of 
Complex Interventions (CICI) framework to identify contextual determinants of problems in 
TB care. Between February and November 2019, we used mixed methods in six public-sector 
primary healthcare facilities and one public-sector hospital serving impoverished urban and 
rural communities in the Amajuba district of KwaZulu-Natal province, South Africa. 
Qualitative data included stakeholder interviews, observations and documentary analysis. 
Quantitative data included routine data on sputum testing and TB deaths. Data were 
inductively analysed and mapped onto the seven CICI contextual domains.  
Results: Delayed diagnosis was caused by interactions between fragmented healthcare 
provision; limited resources; verticalised care; poor TB screening, sputum collection and 
record-keeping. One nurse responsible for TB care, with limited integration of TB with other 
3 
 
conditions, and policy focused on treatment adherence contributed to staff stress and limited 
consideration of patients’ psychosocial needs. Patients were lost to follow up due to 
discontinuity of information, poverty, employment restrictions and limited support for 
treatment side-effects. Infection control measures appeared to be compromised by efforts to 
integrate care. 
Conclusions: Delayed diagnosis, limited psychosocial support for patients and staff, patients 
lost to follow-up and inadequate infection control are caused by an interaction between 
multiple interacting contextual determinants. TB policy needs to resolve tensions between 
treating TB as epidemic and individually-experienced social problem, supporting 
interventions which strengthen case detection, infection control and treatment, and also 
promote person-centred support for healthcare professionals and patients.  
 
Keywords 




Despite substantial progress and renewed political commitment to its eradication, 1.4 million 
deaths during 2019 makes tuberculosis (TB) the highest source of global infectious disease 
mortality before the coronavirus disease 2019 (COVID-19) pandemic (1). The End TB Strategy 
established a key set of targets during the 2014 World Health Assembly, committing countries 
to achieve a 95% reduction in TB deaths and a 90% reduction in TB incidence (compared with 
2015 levels) by 2035 (2). While South Africa, long a high-burden TB country, has made 
important strides in this direction, the country’s TB epidemic continues to impose a 
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substantial burden on its health system and people — South Africa’s 2019 TB incidence rate 
of 615 per 100 000 population is exceptionally high compared against the global average of 
130 per 100 000 (1); there is a 58% undetected TB burden in the community (3); and in 2017 
TB was the leading cause of death overall, contributing 6% of all deaths (4). In addition to 
being among the top ten high-burden TB countries, South Africa has been designated one of 
the 20 countries where there is an overlap in high burdens of TB, multi-drug resistant 
tuberculosis (MDR-TB) and TB-HIV coinfection, with 58% prevalence of HIV among TB incident 
cases (1). In 2018, the annual incidence of MDR-TB was 19 per 100 000, and the 71% 
treatment success for new and relapse TB cases in 2018 was substantially lower than the 
global average of 85%, partly due to the high case fatality rate (1). MDR-TB poses a 
disproportionate burden on the South African TB budget (11% of total) because of the cost of 
medications used to treat MDR, including bedaqualine which South Africa has chosen to 
rollout widely (1). These figures are especially troubling given that approximately 160 000 
people with known active TB are lost to follow-up (4). 
 
There are many reasons for the country’s protracted battle with TB. South Africa’s large 
socioeconomic inequities are well-known, and together with HIV, have led to TB flourishing 
among vulnerable populations who live in poverty, in high-density areas. Importantly, TB 
cannot be divorced from the country’s colonial and apartheid past, where labour migration 
from Bantustans to economic areas, was accompanied by little to no health system 
development for specific racial groups (5, 6). Post-1994, many structural inequalities 
persisted, rapid urbanisation and the development of high-density living areas unfolded, 
along with abject poverty and further labour migration – especially in mining and industrial 
factory sectors (7). The HIV epidemic in South Africa has been the most important 
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determinant of TB incidence since 2000, with annual TB incidence rates increasing from 
around 400 per 100 000 population in 2000 to around 1300 per 100 000 population in 2007, 
as HIV prevalence increased (8). Subsequently, the wide-scale implementation of 
antiretroviral treatment, which began in 2004 and reached 5.9 million people living with HIV 
by 2019, has been the main determinant of reductions in TB incidence to around 600 per 100 
000 per year by 2019. A major achievement of the post-apartheid government was however 
the massive expansion of primary health care facilities, particularly in impoverished rural and 
urban areas, which had been severely lacking under apartheid. Although this provided 
reasonable geographical access to a network of about 3500 public sector primary care 
facilities throughout the country, providing free care, the quality of health care in these 
facilities was often lacking, partly due to constraints in the availability of adequately trained 
health professionals.  
 
South Africa’s public health system underperforms in the implementation of national TB 
management guidelines, compared to targets. In 2018–2019, provincial TB screening rates 
(patients asked about TB symptoms) for patients aged 5 years and above ranged from 47% to 
98%, with only two of the nine provinces reaching the 90% target. TB sputum testing for 
symptomatic patients over 5 years ranged from 36% to 99%, with just over half of all districts 
meeting the 90% target (4). Failure to achieve the targets along the TB care cascade 
(screening, testing, diagnosis, linkage to care, retention to care) is associated with multiple 
health system delivery failures (9). These include poorly organised and understaffed primary 
healthcare facilities, poor communication of test results, negative staff attitudes towards TB 
(10), poor integration of HIV and TB services, medication stock-outs, and inadequate 
information technology, infrastructure, data capture and monitoring systems (11). The 
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COVID-19 pandemic has added to the country’s TB health system woes. The focus on COVID-
19 was accompanied by a rerouting of resources from TB programmes to address COVID-19, 
with dramatic reductions in TB case detection and treatment completion, leading some to 
warn that we risked greater losses from TB than from COVID-19 itself (1, 12). Further, COVID-
19 shares many symptoms with TB, increasing complexity of diagnosis, has competed for 
scarce mask and GeneXpert resources, and is associated with a more than two-fold risk of 
death especially during active disease (13).  
 
In addition to these health system problems, the role of people and the patient as active 
components of the health system have been neglected, with patient level factors found to 
impact negatively on care-seeking and adherence. These include low levels of TB knowledge 
among service users (14), lack of patient empowerment (15), high levels of psychosocial 
distress that inhibit volition to self-manage (14); dual stigma with HIV (10), and socio-
economic disadvantage that impede people attending clinic appointments due to high 
transport costs and potential loss of income (16, 17).  
 
Against this backdrop, the need for health systems strengthening that includes a person-
centred orientation is essential. Person-centredness in care aims to: 1) give primacy to a 
person’s unique subjective experiences and interpretations of illness or disability by 
considering psychosocial dimensions alongside biomedical symptomology, 2) promote 
service-user empowerment in decision-making, and 3) prioritise relationships in care and 
treatment (18). Our recent scoping review found little evidence of person-centred care 
interventions being deployed for people with tuberculosis (19). Moreover, despite extensive 
documentation of TB programme failures, there has been little theoretical development of 
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how contextual features of healthcare systems interact with people’s lives to produce poor 
service delivery and poor outcomes for patients. To address this gap, we conducted a case 
study to explore these relationships and generate theoretical propositions to inform 
development of a health system strengthening intervention to improve TB care delivery. 
 
This study forms part of a broader five-year research programme (ASSET) with pre-
implementation, intervention development, and pilot and evaluation phases, closely aligned 
with the Sustainable Development Goal of Universal Health Coverage, conducted across four 
countries - Ethiopia, Sierra Leone, South Africa, and Zimbabwe (20). ASSET has an overall aim 
of developing and evaluating effective and sustainable health system strengthening 
interventions that support the translation of evidence-based practices that promote 
equitable person-centred care into routine health services. This article reports findings from 
the pre-implementation phase of one of the ASSET work packages to provide the theoretical 
basis for developing health systems strengthening interventions to strengthen person-
centred TB care so as to improve key TB outcomes in South Africa.  
 
METHODS 
The study aimed to develop hypothetical propositions regarding the contextual determinants 
of problems in TB care in South Africa. To do so we devised a theory-building case study design 
(21) using mixed methods, comprising stakeholder interviews, observations of TB care, 
documentary review of national TB guidelines and policies and routinely available data 
collected between February and November 2019. To ensure coherence and wider theoretical 
generalisablity of findings across pre-implementation, intervention development and 
evaluation phases, we adopted the Context and Implementation of Complex Interventions 
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(CICI) framework (22). CICI is a determinant and evaluation framework comprising three 
dimensions — context, implementation and setting — which interact with one another and 
with the intervention. For the pre-implementation phase we focused on CICI’s seven 
contextual domains as a means for developing hypothetical propositions on the contextual 
determinants of problems in the delivery of TB care, including: geographical, epidemiological, 
socio-cultural, socio-economic, ethical, legal and the political domain.  
 
Study setting 
The setting was six public-sector primary healthcare (PHC) facilities or clinics and one public 
sector hospital serving impoverished urban and rural communities in Amajuba district of 
KwaZulu-Natal province, South Africa (see Table 1). In 2017, 7.4% of all deaths in KwaZulu-
Natal were due to TB (23), with a high case fatality rate of 11% (24), and in Amajuba TB 
represented the highest cause of death (23). Amajuba district municipality is a geographically 
small (7102 km2) district in North-Eastern KwaZulu-Natal, comprised of three local 
municipalities (Newcastle, eMadlangeni and Dannhauser), eight towns, with a mix of urban, 
peri-urban and rural areas. The population is mainly isiZulu-speaking. The District has a total 
population of 556 580 (0.9% of South Africa) and 127 000 households, 12.3% of which live in 
informal dwellings. In 2019, 416 000 people lived in poverty, an increase of 11.3% from 2009. 
The largest economic sectors are community services, manufacturing, and financing (25).  
 
TB care provision in Amajuba is governed by National TB guidelines and protocols (see 
Additional File 1 for description) (26, 27) and in 2019 the Amajuba district health 
department highlighted the need to address TB mortality as a key priority. Three PHC 
facilities and the hospital outpatient department were initially selected for inclusion and 
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data collection conducted in February 2019. We completed additional data collection in 
November 2019 in two of these PHC facilities, as well as an additional three facilities, at the 
request of the health department to assess screening processes and practices in greater 
detail.  
   






















PHC Facility 1a 
 
Rural 21 EN (Vital 
signs room) 
Outside Area 1 PN 4279 Not 
available 
PHC Facility 2 a, b Rural 38 (17 CCGs)  Outside area 1 PN 4941 5000 
PHC Facility 3 a, b,* Urban 26 EN/ENA/PN 
(7 screening 
points) 
Outside area 1 PN 8377 Not 
available 
PHC Facility 4 b Rural 20 (10 CCGs) EN (Vital 
signs room) 
Outside area 1 PN 4492 2000 
PHC Facility 5 b Rural 18 (25 CCGs) EN (Vital 
signs room) 
Outside area 1 PN 5387 4000 
PHC Facility 6 b Rural 20 (17 CCGs) EN (Vital 
signs room) 
Outside area 1 PN 4826 2000 
Hospital TB 
Outpatient 7 a,* 






All staff 1772 Not 
available 
 
a Facilities and hospital included in first stage of data collection. 
b Facilities included in second stage of data collection. 
*January 2018 to January 2019 
PN – Professional Nurse 
EN – Enrolled Nurse 
ENA – Enrolled Nurse Assistant 
CCG – Community Caregiver 
 
Study population, sampling and recruitment 
Primary healthcare facility staff:  We recruited facility managers to inform our understanding 
of the organisation of TB care; and purposively sampled nurses, doctors, counsellors and 
community caregivers who were treating patients at each of the primary care facilities in the 
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selected district to be interviewed and/or observed. We also recruited nurses who were not 
routinely seeing TB patients as well as a private sector general practitioner and one traditional 
healer to understand their perspectives about the organisation of TB care, and of TB and the 
management of it. 
 
Patients: To be eligible for interview, patients diagnosed with TB needed to have taken 
treatment for at least one month, in order to be able to inform us about their experience of 
care. Eligible patients who arrived at the facility on each day of data collection were 
consecutively sampled. Nurses identified eligible patients and informed the research team 
who then approached the patient about participation in individual interviews.  
 
In the second stage of data collection, patients who screened positive for TB symptoms 
(‘presumptive TB’) were also interviewed after vital signs’ assessment. Nurses informed 
patients about the research, and if the patient was willing, notified the researcher who 
approached the individual about participating in a short interview. Informed consent was 
taken and interviews were audio-recorded. 
 
Other stakeholders: Other key stakeholders were identified and purposively sampled to 
obtain a broader range of perspectives of service delivery, including researchers working for 
the Desmond Tutu Tuberculosis Centre (https://blogs.sun.ac.za/dttc/), TB managers at 
district and provincial level, and members of TB Proof, a NGO which started representing 
health workers with occupational TB and which now represents the views of people living 





Individual interviews: Interviews were semi-structured and carried out in the language most 
appropriate to each participant (isiZulu = 29; English = 19), audio recorded, translated and 
transcribed in English. Interviews in English were conducted by RC (clinician and social 
scientist), AvR (social scientist), JM (social scientist) and AD (social scientist). Interviews in 
isiZulu were conducted by AD, supported by two fieldworkers trained in qualitative interview 
methods who lived locally and were known to the participating clinics. AD worked with the 
fieldworkers to translate the interview topic guides, identifying how best to adapt questions 
to retain the intended meaning when asked in isiZulu. The interview team carefully 
considered who was best placed to carry out different interviews so that participants would 
feel comfortable to disclose their experience and perceptions of TB care provision but also 
potentially sensitive topics such as stigma and psychological distress. The local fieldworkers 
were critical in this regard, facilitating insights into patients’ experiences which were perhaps 
less likely to be disclosed if conducted by another team member. Following national guidance 
on the ethics of payment, incentives to participate were not offered as interviews took place 
following the patient’s consultation and did not require additional travel or time off work to 
be interviewed (28).  
 
For individual interviews with patients, semi structured questions were avoided to minimise 
the researcher imposing their own assumptions on participants’ experiences during the 
interview. Instead the researcher elicited stories (29) of patients’ journeys through the TB 
care pathway from the point where they first noticed symptoms through to treatment and 
followed up topics as they arose. Patients who screened positive for TB were briefly 
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interviewed to elicit their understanding of the screening questions, instructions for providing 
sputum testing and next steps for their care.   
 




Health care workers 
 
Facility Managers 5 
Provincial managers 1 
TB district managers 1 
Community Caregivers 2 
Doctors 3 
Professional Nurses 3 
Traditional Healer  1 
Non-Governmental 
Organisations 
Desmond Tutu TB centre researchers 1 















More than 1 month, duration uncertain 2 
Less than 2 months 9 
2-8 months 6 









General Practitioner 4 
Type of TB MDR-TB 6 
Drug sensitive TB 14 
Patients with 
Presumptive TB 
 Male 5 
Female 4 
 
Interviews with nurses, counsellors, community caregivers and doctors explored the provision 
of TB care, implementation of infection control measures, and solutions for strengthening TB 
care. Interviews with provincial managers and stakeholders explored current services and 
interventions to support people with TB, interventions to reduce TB infection and address 
psychological needs of patients with TB, and perspectives on required interventions to 




Interviews conducted in isiZulu were translated and transcribed by one of the fieldworkers to 
help ensure the meaning of participants’ responses were retained rather than a direct literal 
translation. RC and AD then reviewed all isiZulu recordings and transcripts to identify and 
resolve any potential misrepresentation from the original meaning.  
 
Healthcare facility observations: Within all six primary healthcare facility we carried out 
periods of direct, non-participant observations within non-clinical areas to understand the 
organisation and process of TB care including patient flows, TB screening and testing, 
infection control measures and data capturing processes. We recorded contemporaneous 
written field notes of their observations using a semi-structured observation guide (Additional 
File 2).  
 
Documentary and routine data review:  Relevant policy and guidelines (Additional File 1), 
district TB mortality reports and routine data (24) were reviewed to identify best practices for 
TB screening, testing, diagnosis, treatment initiation, infection control and follow-up of 
patients, mortality burden and data system bottlenecks.  
 
Data analysis 
In order to generate hypothetical propositions on the contextual determinants of problems 
in TB care delivery, we identified relationships between CICI domains and across macro-
contextual features (e.g. national and international healthcare policy, discourses, infra-
structural relations, socio-economic factors), meso-contextual features (i.e. organisation of 
TB care at a primary healthcare facility level), and micro-contextual features (i.e. patients’ and 
clinician’s behaviour). We drew on Braun and Clarke’s thematic analysis as a ‘contextualist’ 
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method (30), examining how macro-contextual features shaped meso and micro (or vice 
versa), thereby tracing a thread between specific perspectives or observations to the broader 
social historical context in which they were manifested (see Figure 1). Rather than necessarily 
developing higher-order themes within the discrete datasets, this approach required treating 
each participant report or observation as a potential contextual feature which we then 
explored within and across contextual levels and across data types to develop and test 
emerging theories (31), for example how reported implementation of infection control 
measures matched recommended practice within TB guidelines as well as our observations 
within the facility. This iterative approach enabled us to transition from the particularities of 
Amajuba as a single case to theoretical explanations of how different contextual determinants 
applicable in other South Africa settings may shape the patterns we observed, facilitating 
generalisable inferences and predictions on what kinds of intervention components are 
needed to tackle different contextual determinants of problems in TB care.  
 
All interviews were inductively coded for features using the qualitative data analysis software 
NVivo 12 (QSR International, https://www.qsrinternational.com/nvivo/home ). This provided 
detailed staff, manager and stakeholder perspectives of the process and content of TB care 
in facilities; and for patients, pathways to care, and experiences of living with and managing 
TB. Initially four researchers (RC, AD, JM, AvR) coded two of the same interviews and 
compared these to identify and resolve differences. The facilities were then divided between 
these research members, with the coding of features checked by JM. A constant comparison 
approach was adopted, working iteratively between data obtained from different 
interviewees within and between facilities to test out categories, including searching for 
disconfirming cases (32). First order codes were then analysed to consider if they could be 
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developed into higher order codes to better facilitate understanding of emerging 
relationships between contextual features. Field notes were analysed to provide a detailed 
description of the process and content involved in provision of TB care, including screening, 
testing, data capture and infection control measures. 
 
 
Data synthesis within CICI framework: As the analysis developed we mapped contextual 
features onto the seven contextual domains of the CICI Framework. Any feature which did 
not readily map onto a domain was discussed and assigned to a domain or an additional 
domain added. We then analysed the mapped domains in light of emerging theories to 
generate hypothetical propositions which specified the contextual determinants of problems 
in delivering effective person-centred TB care. Finally, we hypothesised which intervention 
components and implementation strategies would logically tackle those determinants. 
Throughout analysis, we held regular meetings between all project team members and the 
district health department to review findings, discuss emerging theories on the relationship 
between features and contextual domains, and later develop hypothetical propositions and 
intervention components.  
 





The key ethical principles of voluntary and informed participation, confidentiality and safety 
of participants were used in all researcher and participant interactions.  Written consent for 
interviews was obtained from all stakeholders, facility managers, clinicians and patients. 
Facility managers provided consent for observations of non-clinical areas. All participants 
were provided with written information about the research, informed that their participation 
was voluntary and that they could withdraw from participation at any time. Patients were 
typically approached after their consultation and interviews were conducted in outdoor areas 
with researchers wearing a mask where possible. 
 
RESULTS 
We identified a diversity of contextual features of TB care which cut across the CICI 
framework’s epidemiological, socio-economic, political, socio-cultural, ethical, legal and 
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geographical domains, and an additional institutional domain (Additional file 3). Contextual 
determinants of problems in TB care interacted across macro-, meso- and micro-contextual 
levels contributing to delayed TB diagnosis, limited support for staff and patients’ 
psychosocial needs, patients lost to follow-up after diagnosis, and inadequate infection 









Delayed diagnosis at community and facility level 
Patients reported a range of referral pathways (Figure 2) from the point of noticing symptoms 
to diagnosis and treatment initiation, in one case involving three doctors, (including private 
doctors) over a two-month period before being diagnosed with MDR-TB. Fragmented data 
recording and sharing underpinned such delays which was also reflected in delays retrieving 
sputum test results from laboratories, leading to loss of follow up or delayed diagnosis and 
treatment. Within facilities, there was typically one room dedicated for TB patients and care 
provided by one professional nurse. Ideal Clinic policy requires that nurses screen patients for 
TB in vital signs rooms, asking four questions: ‘Do you have a cough?’; ‘Do you have a fever?’; 
‘Have you lost weight?’; and ‘Are you sweating a lot at night?’ However, we observed wide 
variation in TB screening practices, taking place within and outside vital signs rooms and 
inconsistent questioning of patients, sometimes only occurring if patients showed signs or 
symptoms. Within some facilities, data recording of patients screened was incomplete and 
inaccurate, including discrepancies between numbers of patients observed and recorded; and 
missing screening data for chronic condition patients. Instructions to provide sputum at home 
or in the clinic varied both within and between clinics, with some patients asked to revisit the 
clinic with the sample. However, patients screening positive for TB were not recorded in a TB 
register until they returned their sputum. Patients also reported being confused about how 
to provide sputum, how much sputum to produce and when and where to return the sample. 
Only two facilities reported that they supervised sputum collection. This was reflected in high 
rejection rates of sputum samples. For the period of January to August 2019, the two main 
reasons for rejected samples in the district were insufficient specimen (44%) and leaked 




Other issues causing delays were patients having a preference for private doctors, accessing 
traditional healers as a first point of contact and delayed presentation to public sector health 
services. Several staff reported that patients provided incorrect addresses citing privacy 
concerns including not wanting to be seen attending their local clinic or having CCGs follow 
them up in their homes.  
 
Limited support for psychosocial needs of staff and patients 
Patients reported how key aspects of their life had been lost since being diagnosed with TB, 
including control of their body, mental state, professional role, social contact and personal 
relationships. These different forms of loss can be seen to represent a ‘loss of self’ (33) as 
patients struggled to adjust to the changes in their lives, highlighting a need to provide 
psychosocial support from the point of diagnosis through to treatment completion. However, 
both staff and patients frequently presented care as having a biomedical focus on treatment 
adherence, with limited discussion of the psychosocial support patients may require or how 
to continue with everyday activities that are important to patients. 
 
The loss of social contact and personal relationships arising from patients choosing to self-
isolate during the early weeks of their treatment was intimately connected to a moral 
incentive not to infect others. For some this created a stigmatising element to their 
relationships, with friends or relatives distancing themselves from the diagnosed patient. 
Stigmatisation and fear of being infected shaped how some staff reported being stressed 
about providing TB care, and in one facility we observed staff visibly recoiling at the 
suggestion that they might need to take on this role. An exception to this was one nurse 
whose expressed commitment to caring for individuals living with TB functioned to articulate 
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the otherwise wider stigmatisation and marginalisation of this group: ‘You know if people are 
sick with TB, nobody loves them.  Nobody likes them. Nobody wants anything to do with them. 
I said, if they cannot be loved by anyone, why can’t I love them. That is what keeps me here 
each and every day. Just to give my love to them. To understand them and to love them, and 
to attend to their needs.’ (TB nurse) 
 
Patients lost to follow-up after diagnosis or end of treatment initiation phase 
An important contextual feature shaping the ability of patients to adhere to treatment and 
for facilities in following patients through to treatment completion is the level of 
unemployment, at 39.1% in 2014 (34). A large proportion of the community live in high-
density housing, which is likely to increase the risk of TB transmission. Patients and clinicians 
reported difficulties in attending facilities to collect treatment (and therefore medication 
adherence) because transport costs are required. Many patients are daily paid workers 
within manufacturing industries with working conditions which restrict their ability to 
flexibly attend clinic appointments. Related to this are working migration patterns, with 
some patients working away from home and then returning to collect medication, 
potentially creating discontinuities in treatment, made worse if patients provide the wrong 
address or move without informing the facility. 
 
The reported focus of consultations on ensuring patients were adherent to medication was 
set against little evidence of patients being supported to deal with medication side-effects 
either through expressions of empathy or provision of medication to assist with them.  
 
Inadequate infection control alongside policy to minimise TB stigma 
22 
 
A particular challenge for minimising the stigma surrounding TB is the subtle interaction with 
the need to take appropriate infection control measures. Integration of HIV care into chronic 
care services has helped reduce stigma in South African primary care (35, 36). Ideal Clinic 
policy builds on this by extending this arrangement to those with TB, after the intensive phase 
of treatment has been completed. While these patients should be non-infectious, in practice 
we observed patients with TB at various stages of treatment sitting with others attending for 
other chronic conditions. We also noted inconsistent use of masks by nurses and patients, 
potentially revealing spaces where the tension between infection control and stigma creates 
individual uncertainty about what measures are appropriate and should be taken to reduce 
infection. 
 
Primary care facility infrastructure did not help minimise the spread of TB, including long 
corridors with few windows. We observed patients with TB sat close by other patients 
including pregnant women and children, and clinical staff reported the difficulties in 
maintaining appropriate infection control measures. This included patients already 
commencing TB treatment and those yet to start treatment, with the latter posing a greater 
risk of transmission than the former. In contrast, at the hospital site, dedicated to treating 
both drug-sensitive and MDR-TB, patients sat in open air waiting areas, masks were routinely 
worn in all inpatient wards and outpatient consultation rooms, and a team of staff deployed 
to treat the range of patients requiring care. 
 
DISCUSSION 
Achieving WHO End TB strategy targets (2) urgently requires interventions that strengthen 
the healthcare system to better identify, test and diagnose people with TB and to support 
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them to successfully complete the TB treatment pathway. Our findings highlight that to do so 
requires careful consideration of how different contextual features interact to produce 
different problems in the delivery of TB care. We have provided hypothetical propositions, 
and recommendations for potential intervention components and implementation strategies 
to facilitate this process, pinpointing relationships between policy, the infrastructural 
organisation of primary healthcare, and discourse at a macro-contextual level; the 
operationalisation of policy within primary care at a meso-level; and how these contextual 
conditions come to be manifested at a micro-level where patients seek and receive care.  
 
There is a pressing need to improve systems of TB screening, testing, data capture as well as 
developing interventions that function to destigmatise TB within communities. Patients 
frequently present to services some time after onset of symptoms and may have multiple 
contacts over weeks or months before receiving a diagnosis. Fragmented service provision 
and under-resourced public services reinforce these delays undermining data sharing, 
referrals, and efficient screening and testing procedures. Within clinics, we identified variable 
quality in TB screening, sputum testing and data capture, and patients were unclear about 
how to provide sputa samples. Strengthening patient education and systems for screening 
and testing within public facilities are required to reduce delays to diagnosis and treatment, 
supporting similar findings in previous research (9-11). Although some determinants such as 
poverty and distribution of employment are societal challenges that require systemic 
intervention over decades, recognition of these difficulties highlights the need to ensure 
patients taking TB medication have access to food (15), as well as the potential of inter-
sectoral collaboration between health and industry to support employees to attend facilities 




Our study identified specific tensions between two broad policy agendas that have very 
different underpinning assumptions and framings of what type of problem TB represents, 
shaping what practices healthcare professionals enact and therefore the care of patients. On 
the one hand, TB policy (1, 2) is predominantly orientated towards reducing the mortality and 
incidence of TB, which discursively frames the illness as a population-based disease epidemic, 
inherently placing TB screening, testing, diagnosis, treatment adherence and TB infection 
control measures at the heart of protocols and practice for healthcare facilities, healthcare 
workers, patients and communities. At the same time, there is recognition that this agenda is 
at odds with a person-centred view of TB care (2), which constructs the condition as an 
individually-experienced social problem, facilitating understanding of how TB has impacted on 
individual’s participation in society and their associated psychological, emotional and mental 
health.  
 
These different orientations are not necessarily mutually exclusive. However, our findings 
highlight how the global discourse of TB as epidemic can dominate clinical practice at the 
expense of the individual, seen in terms of patient’s psychosocial problems not being elicited 
within consultations, but also the individual concerns of healthcare workers who may be the 
sole person responsible for TB care. The realities of operationalising these two agendas 
without one undermining the other requires multi-faceted and nuanced strategies for 
supporting healthcare workers and patients through the TB treatment pathway. Disease-
specific policies and guidelines in low and middle-income countries (LMICs) have historically 
functioned to verticalise care of chronic illnesses (38, 39), and despite the promotion of 
integrated care within facilities, this institutionalised practice places responsibility for 
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meeting TB targets in the hands of individual nurses. South Africa’s Integrated Chronic Disease 
Management programme has also made progress in integrating primary care for HIV and 
NCDs, but TB care remains separate, partly due to the need to prevent transmission within 
facilities and report on TB treatment outcomes. Important interventions therefore lie in 
ensuring TB policy recognises the challenges clinicians face in providing TB care, identifying 
strategies for enabling the collective management of TB, training all staff to provide that care, 
and providing support for staff to manage anxieties about TB infection.   
 
Such interventions broaden the scope of person-centred care to incorporate clinicians in 
addition to patients and their families, and in doing so, may function to facilitate more holistic 
care of individual patients. As well as integrating care for HIV, TB and non-communicable 
conditions, prioritising a focus on the relationship between psychosocial health and TB 
treatment adherence may be critical for supporting the emotional, social and mental health 
needs of patients as a mechanism to enhance treatment adherence. Evidence is already 
available which has demonstrated the links between stigma, depression, family and 
community support, and non-adherence for patients with TB (40-46). However, efforts to 
improve TB treatment outcomes have not prioritised identification and management of 
stigma and depression, and research in this area remains scarce and limited to MDR-TB or 
those hospitalised for treatment. Our recent scoping review (19) which identified a paucity of 
person-centric TB care being delivered across LMICs, found only two studies, both based in 
Nepal, which focused on psychosocial support of patients with MDR-TB (47, 48).  
 
Interventions that orientate to the interaction between TB stigma and psychosocial health 
might be undermined by infection minimisation strategies that function to reinforce and 
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perpetuate such stigma. South Africa introduced a TB infection control programme in 2007 
(updated in 2012) with a structural review of healthcare facilities and TB infection control 
practices, as well as development of minimum standards for health facilities (49). However, 
while in most high-income countries it is standard practice to isolate people who are 
potentially infected with TB, in many LMICs this rarely happens and is often perceived to be 
discriminatory (47, 50). The boundaries between appropriate infection control measures and 
actions that function to reinforce TB stigma are therefore blurred and despite the availability 
of legislation, guidelines and policies, we found implementation of TB infection control is 
generally poor and adherence of health care workers is sub-optimal, echoing previous 
research (51-53). This has created an ethical paradox between attempts to minimise TB 
stigma and the implementation of infection control policies which have arguably led to 
indecision within healthcare facilities about what infection control measures are appropriate 
and consequentially the less than optimal practices we observed.  
 
The range of factors that perpetuate the South African TB epidemic have been rendered all 
the more complex with the onset of the COVID-19 pandemic, which has already had dire 
consequences for TB care (54). Not only is little known about the incidence, risk and course 
of illness of COVID-19 in people with undiagnosed pulmonary, drug-resistant or complex TB 
presentations but COVID-19 shares many symptoms with TB, such as cough, fever, and 
shortness of breath, making differentiating between COVID-19 and TB challenging for 
healthcare workers. On the other hand, the normalisation of mask wearing and increased 
awareness around infection control practices has potential to destigmatise these measures 




This study took place in one district in South Africa with a high burden of TB, limiting direct 
transferability of our findings to other parts of South Africa and other LMICs. However, by 
focusing on Amajuba as a theory-building case study (21) we have generated hypothetical 
propositions which trace a thread between global forces on the identification, diagnosis and 
treatment of TB and the actions of individual clinicians and patients who face the realities of 
managing TB in everyday life. In doing so we offer theoretical generalisability on the 
contextual determinants of TB that echo across LMICs with a high burden of TB, providing a 
foundation for developing interventions to tackle those determinants. 
 
In setting out the domains and contextual determinants of TB care, we are conscious that the 
foundations of our findings lie in the situated perspectives of participants and our own 
observations of TB care. We are not claiming to have objectively established causal 
relationships between domains, TB care and rates of TB cases and fatalities. However, the 
breadth of data we have collected, the depth of analysis and triangulation across data types 
provide strong foundations for the hypothetical propositions we propose. Concrete 
intervention development work is now required, using the recommendations for intervention 
components and implementation strategies as a starting point for further development and 
specificity. 
 
Our sample was limited by staff availability and according to which patients presented on the 
day of data collection and whom were willing to participate. Negotiating access to facilities to 
conduct fieldwork required numerous communications to build trust between district 
managers, facility staff and the research team, which in itself revealed the burden of 
accountability experienced by staff responsible for reducing TB morbidity and mortality 
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within this district. Interviews and observations were sometimes difficult to conduct in busy 




Significant health systems strengthening interventions are required if WHO targets for TB are 
to be achieved in South Africa by 2035. To do so requires careful consideration of how 
different contextual determinants interact to produce problems in the delivery of TB care. 
Strengthening the quality and processes for screening, testing and diagnosing patients within 
primary healthcare facilities are essential but need to be supported by policy that resolves 
tensions between treating TB as a population-based epidemic and TB as an individually-
experienced social problem. At the heart this are TB nurses who need to practise in a climate 
of stigma, infection control measures and accountability for ensuring patients complete the 
TB treatment pathway. Structuring TB care as a collective endeavour within facilities 
underpinned by a person-centred ethos of support for colleagues may help ensure the same 
principles are translated to supporting patients to manage not just the condition but their 
experience of TB. Future research should focus on co-producing health system strengthening 
interventions and implementation strategies with staff, policymakers and patients to help 
ensure the different priorities of these respective stakeholders can be aligned and feasibly 
delivered in everyday clinical practice. Such an approach will coherently follow from 
understanding the complex interaction between contextual determinants of TB care 
provision, including how COVID-19 contributes to that complexity. Subsequent mixed 
methods implementation research will therefore be critical, designed to provide robust 
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evidence for wide-scale implementation of multi-faceted, health systems strengthening and 
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